BLACKROCK ADVISORS LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$18,971,000
+18.6%
371,543
+6.9%
0.02%
+18.8%
Q3 2016$15,999,000
+126.1%
347,425
+47.9%
0.02%
+128.6%
Q2 2016$7,076,000
+83.5%
234,866
+95.2%
0.01%
+75.0%
Q1 2016$3,857,000
-44.1%
120,315
+1.6%
0.00%
-42.9%
Q4 2015$6,902,000
+34.1%
118,389
-2.7%
0.01%
+16.7%
Q3 2015$5,148,000
-60.3%
121,656
-31.5%
0.01%
-53.8%
Q2 2015$12,965,000
-10.7%
177,600
-38.5%
0.01%
-13.3%
Q1 2015$14,512,000
+536.8%
288,917
+363.9%
0.02%
+650.0%
Q4 2014$2,279,000
+91.7%
62,276
+65.0%
0.00%
+100.0%
Q3 2014$1,189,00037,7500.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders